Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rami Lutfi

Surgery Chicago, IL Medical Doctor

NPI 1447237425 CMS profile 292437

200 W Superior St Ste 300, Ste 300, Chicago, IL 60654

Open in the dashboard

General payments

$410,856

823 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rami Lutfi of Chicago, IL is reported in the CMS Open Payments database as having received $410,856 across 823 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,190 75
2024 General $31,860 96
2023 General $169,331 238
2022 General $40,407 122
2021 General $68,840 144
2020 General $16,453 35
2019 General $64,775 113

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rami Lutfi
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Rami Lutfi were reported at $19,190. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Rami Lutfi Surgery median Middle half National median
2019 $64,775 $253 $82–$1,521 $163
2020 $16,453 $131 $40–$706 $114
2021 $68,840 $168 $50–$904 $132
2022 $40,407 $224 $76–$1,218 $149
2023 $169,331 $253 $82–$1,255 $160
2024 $31,860 $279 $90–$1,381 $164
2025 $19,190 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $235,306 530 payments
  2. W. L. Gore & Associates, Inc. $94,901 143 payments
  3. Olympus Corporation of the Americas $36,879 50 payments
  4. Olympus Latin America, Inc. $16,444 20 payments
  5. Ethicon US, LLC $5,652 12 payments
  6. Covidien LP $5,034 25 payments
  7. Ethicon Inc. $3,539 5 payments
  8. Gyrus ACMI, Inc. $2,689 2 payments
  9. Baxter Healthcare $2,550 1 payment
  10. Medical Device Business Services, Inc. $2,325 1 payment
  11. Other $5,536 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $150,822 71 payments
  2. Consulting Fee $135,218 53 payments
  3. Travel and Lodging $37,745 207 payments
  4. Food and Beverage $32,171 469 payments
  5. Education $30,340 17 payments
  6. Honoraria $24,510 5 payments
  7. Entertainment $51 1 payment
Products named General payments · program years 2019–2025
  1. GORE SEAMGUARD Bioabsorbable Staple Line Reinforce $48,215 65 payments
  2. Signia $39,984 245 payments
  3. LigaSure $28,753 57 payments
  4. SEAMGUARD Bioabsorbable Staple Line Reinforcement $27,073 38 payments
  5. 4-K $21,750 22 payments
  6. GORE BIO-A Tissue Reinforcement $21,093 5 payments
  7. Sonicision $17,790 90 payments
  8. SEAMGUARD Staple Line Reinforcement $14,601 16 payments
  9. GORE ENFORM Preperitoneal Biomaterial $14,160 3 payments
  10. Olympus Surgical Accessories $13,512 10 payments
  11. Other $110,743 251 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$31,817

Medicare's payments for the services billed

Medicare patients

82

Average age 69

Services billed

161

62 women, 20 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Diabetes 45%
Chronic kidney disease 38%
Depression 35%
Heart failure 28%
Ischemic heart disease 26%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

823 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record